Pasar al contenido principal

EVALUACION COSTE-EFECTIVIDAD DEL TRATAMIENTO PSICOLOGICO TRANSDIAGNOSTICO INDIVIDUAL VS GRUPAL PARA DESORDENES EMOCIONALES EN ATENCION PRIMARIA

PID2019-107243RB-C22

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE CORDOBA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Helvia. Repositorio Institucional de la Universidad de Córdoba
Publicación Artículo científico (JournalArticle)

Protocol to evaluate the effectiveness of the implementation of transdiagnostic cognitive behavioural therapy for emotional disorders in primary care and its mechanisms of change: a randomized step-wedge clinical trial (PsicAP-CV)

  • Muñoz-Navarro, Roger
  • Pérez-Jover, Virtudes
  • Esteller-Collado, Gabriel
  • Van-der Hofstadt Román, Carlos
  • Salgueiro, Monika
  • Llorca-Mestre, Anna
  • Malonda-Vidal, Elisabeth
  • Canet-Cortell, Vera
  • Moraga-García, M. José
  • Coloma-Carmona, Ainhoa
  • Carpallo González, María
  • Prieto Vila, Maider
  • Barrio Martínez, Sara
  • Aguilera Martín, Ángel
  • Gálvez Lara, Mario
  • Jurado González, Francisco Javier
  • Aguirre, Elisa
  • González‑Blanch, César
  • Ruiz-Rodríguez, Paloma
  • Moriana Elvira, Juan Antonio
  • Samper-García, Paula
  • Mestre-Escrivá, María Vicenta
  • Cano-Vindel, Antonio
Introduction: Emotional disorders (ED) are highly prevalent worldwide. The PsicAP trial, conducted in Spain, demonstrated the benefits of adding transdiagnostic cognitive behavioural therapy (TD-CBT) to treatment as usual (TAU) for the attention of these disorders in primary care (PC). Here we describe the design of a stepped wedge randomized controlled trial (RCT), inspired by the PsicAP project. This RCT has two main aims: 1) to test the implementation of the PsicAP protocol in a real clinical setting, further evaluating possible mechanisms of change underlying the efficacy of TD-CBT (emotional regulation, alliance, and therapist experience and training), and 2) to assess the impact of psychotropic medication use on neuropsychological function and treatment outcomes. Methods: A single-blind multicentre RCT with a stepped wedge design will be conducted. Participants (N=320) will be randomly assigned to an experimental group (EG1) or to a waiting list group (WG). The EG1 will receive immediate treatment and the WG will remain on the waiting list for 3 months. After this time, the WG will become a second experimental group (EG2) that will receive the same treatment as EG1 (PsicAP protocol). Patients will be assessed at post-treatment, at 3 and 9 months. Before starting treatment, a random subsample of patients (n=90) will undergo a neuropsychological assessment. These patients will be assigned to three groups based on their use of psychotropic medication at the time of randomization: no psychotropic medication, short-term use (< 3 months) and long-term use (≥ 3 months). All 90 participants will undergo the same neuropsychological assessment at one year. The RCT is expected to run from 01/05/23 to 01/10/25. Discussion: The results of this trial are expected to provide further support for the efficacy of the PsicAP TD-CBT protocol, as well as insight into the mechanisms of change that lead to the positive therapeutic outcomes of this protocol. In addition, this study will help determine the effects of short- and long-term psychotropic use on neuropsychological function and therapeutic outcomes. In short, it is hoped that this RCT will help to better understand how to implement evidence-based psychological treatment in the PC setting. Trial registration: EURADICT 2013-001955-11/ ISRCTN58437086.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publicación Capítulo o parte de un libro (BookPart)

Psicoterapia transdiagnóstica para trastornos emocionales en atención primaria: protocolo para un ensayo clínico aleatorizado

  • Aguilera Martín, Ángel
  • Gálvez Lara, Mario
  • Moriana Elvira, Juan Antonio
Los trastornos emocionales son los más comunes. En España, la mayoría de ellos se tratan en atención primaria, donde suelen ser incorrectamente evaluados y tratados con medicación. Esto hace que el trastorno perdure y aumenta los costes personales, sociales y sanitarios del mismo. La psicoterapia puede ser una alternativa coste-efectiva, pues sus efectos son más duraderos, su duración puede ser abreviada y un enfoque transdiagnóstico permitiría utilizar la misma terapia para diferentes trastornos e incluso crear grupos terapéuticos heterogéneos. Este protocolo propone un ensayo clínico aleatorizado con medidas pre-post y 2 seguimientos para comparar, en términos de coste-beneficio, una terapia cognitivo-conductual transdiagnóstica breve, tanto en formato grupal como individual, con el tratamiento habitual en atención primaria para trastornos emocionales leves y moderados. Los resultados permitirán comprobar la viabilidad de implementar la terapia psicológica en atención primaria con el objetivo de establecer un sistema de tratamiento escalonado, donde los trastornos más leves sean atendidos en atención primaria con psicoterapia transdiagnóstica y los más graves en atención especializada con la combinación de psicoterapias más específicas y medicación., Emotional disorders are the most common mental disorders. In Spain, most of them are treated in primary care, where they are usually misdiagnosed and mistreated with medication. This perpetuates the disorder and increase personal, social, and healthcare costs. Psychotherapy may be a cost-effective alternative since its effects are more enduring, its duration can be abbreviated, and a transdiagnostic approach would allow using the same therapy for different disorders and even create heterogeneous therapy groups. This protocol proposes a randomized clinical trial with pre-post measures and 2 follow-ups to compare, in cost-benefit terms, a brief, transdiagnostic, cognitive-behavioural therapy, both in group and individual format, with the usual primary care treatment for mild to moderate emotional disorders. Results would allow checking the feasibility of implementing psychological therapy in primary care in order to stablish stepped-care system, where the mildest disorders would be treated with transdiagnostic therapy in primary care and the severest ones in specialized care with the combination of more specific psychotherapies and medication.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publicación Artículo científico (JournalArticle)

Comparing psychological versus pharmacological treatment in emotional disorders: A network analysis

  • Jurado-González, Francisco
  • García-Torres, Francisco
  • Contreras, Alba
  • Muñoz-Navarro, Roger
  • González‑Blanch, César
  • Medrano, Leonardo Adrián
  • Ruiz-Rodríguez, Paloma
  • Moreno, Eliana M.
  • Pérez-Dueñas, Carolina
  • Cano-Vindel, Antonio
  • Moriana Elvira, Juan Antonio
Transdiagnostic group cognitive behavioural therapy (TD-GCBT) is more effective in improving symptoms and severity of emotional disorders (EDs) than treatment as usual (TAU; usually pharmacological treatment). However, there is little research that has examined the effects of these treatments on specific symptoms. This study used Network Intervention Analysis (NIA) to investigate the direct and differential effects of TD-GCBT + TAU and TAU on specific symptoms of anxiety and depression. Data are from a multicentre randomised clinical trial (N = 1061) comparing TD-GCBT + TAU versus TAU alone for EDs. The networks included items from the PHQ-9 (depression) and GAD-7 (anxiety) questionnaire and mixed graphical models were estimated at pre-treatment, post-treatment and 3-, 6- and 12-month follow-up. Results revealed that TD-GCBT + TAU was associated with direct effects, mainly on several anxiety symptoms and depressed mood after treatment. New direct effects on other depressive symptoms emerged during the follow-up period promoted by TD-GCBT compared to TAU. Our results suggest that the improvement of anxiety symptoms after treatment might precipitate a wave of changes that favour a decrease in depressive symptomatology. NIA is a methodology that can provide fine-grained insight into the likely pathways through which treatments exert their effects.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Comparing psychological versus pharmacological treatment in emotional disorders: A network analysis

  • Jurado-González, Francisco
  • García-Torres, Francisco
  • Contreras, Alba
  • Muñoz-Navarro, Roger
  • González-Blanch, César
  • Adrián Medrano, Leonardo
  • Ruiz-Rodríguez, Paloma
  • Moreno, Eliana M.
  • Pérez-Dueñas, Carolina
  • Cano-Vindel, Antonio
  • Moriana, Juan A.
Transdiagnostic group cognitive behavioural therapy (TD-GCBT) is more effective in improving symptoms and severity of emotional disorders (EDs) than treatment as usual (TAU; usually pharmacological treatment). However, there is little research that has examined the effects of these treatments on specific symptoms. This study used Network Intervention Analysis (NIA) to investigate the direct and differential effects of TD-GCBT + TAU and TAU on specific symptoms of anxiety and depression. Data are from a multicentre randomised clinical trial (N = 1061) comparing TD-GCBT + TAU versus TAU alone for EDs. The networks included items from the PHQ-9 (depression) and GAD-7 (anxiety) questionnaire and mixed graphical models were estimated at pre-treatment, post-treatment and 3-, 6- and 12-month follow-up. Results revealed that TD-GCBT + TAU was associated with direct effects, mainly on several anxiety symptoms and depressed mood after treatment. New direct effects on other depressive symptoms emerged during the follow-up period promoted by TD-GCBT compared to TAU. Our results suggest that the improvement of anxiety symptoms after treatment might precipitate a wave of changes that favour a decrease in depressive symptomatology. NIA is a methodology that can provide fine-grained insight into the likely pathways through which treatments exert their effects.